WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs.
WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only been available with expensive, injectable drugs.
The drug from Merck was OK’d on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard medications for cutting heart attack risk. Merck will market its pill under the brand name Lipfendra.
FDA approves 1st-of-its-kind pill to reduce cholesterol
The cholesterol shot you couldn’t afford is now a pill | Fortune
FDA approves first pill to significantly lower 'bad' cholesterol - UPI.com
Merck’s cholesterol pill gets US FDA approval | CNN
Merck gets US FDA nod for first-in-its-class oral cholesterol drug
FDA approves new kind of cholesterol pill
Merck wins first approval of a PCSK9 cholesterol pill
La FDA aprobó la primera pastilla que promete mejorar significativamente el tratamiento del colesterol alto
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio - Merck & Co (NYSE:MRK)
FDA Approves First PCSK9 Inhibitor in Pill Form
The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol…
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.
The Food and Drug Administration on Thursday approved Merck's Lipfendra, which some have hailed as a breakthrough in cholesterol…
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s…
The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9…
A new Merck pill called enlicitide slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs…
